Novo Nordisk Foundation and LanzaTech to develop biofoundry

In Denmark, BRIGHT, the Novo Nordisk Foundation Biotechnology Research Institute for the Green Transition at the Technical University of Denmark (DTU) and LanzaTech Global have entered a multi-year agreement to accelerate development of technologies that convert carbon emissions into valuable products.

The partnership runs until April 2028 and includes the design and installation of a next-generation C1 biofoundry at DTU. This allows LanzaTech to extend its world-class synthetic biology expertise, leveraging BRIGHT’s infrastructure, talent, and regional reach. At the same time, DTU will gain the tools and expertise needed to establish Denmark and Europe as an important player in the emerging field of carbon-to-value biotechnology, accelerating innovation in the field of circular and competitive bioeconomy.

Tags: Denmark, LanzaTech, Novo Nordisk Foundation

Category: Fuels